The Montreal Neurological Institute and Hospital’s Clinical Research Unit (CRU), will hold its 2nd Annual National Clinical Trial Training Program on June 15 & 16, 2017 at the Montreal Neurological Institute and Hospital.
Trial News & Events
NEALS Research Ambassadors, Stephen Winthrop and Pete Frates, were recently interviewed by WCVB, the Boston ABC affiliate, about their commitment to clinical trials and the fight against ALS.
Madeline Kennedy describes the benefits of a multidisciplinary care approach for people living with ALS.
Please join us on March 23rd for a webinar discussion on cannabinoid use in ALS led by Drs. Mark Ware and Angela Genge from the Montreal Neurological Institute and Hospital. Dr. Ware will discuss the mechanism of action of cannabinoids, while Dr. Genge will discuss their use in symptom management, and possible effect on disease course.
Barrow Neurological Institute is seeking individuals to participate in a remote research study called ALS AT HOME, enrolling under the direction of Dr. Jeremy Shefner.
NEALS is pleased to announce a full day training session for NEALS investigators interested in developing and conducting multi-center ALS clinical trials as Principal Investigators.
Neuraltus Pharmaceuticals, Inc., is currently enrolling up to 120 individuals with ALS and evidence of systemic inflammation in a second Phase 2 study of its investigational treatment NP001, an immune system regulator.
At the 6th Annual Les Turner Symposium on ALS and NeuroRepair, sponsored by the Les Turner ALS Research and Patient Center at Northwestern Medicine held in November 2016, a crowd of over 175 attendees learned the latest in ALS research and patient care from experts in the field.
Join Genetic Counselor and Assistant Professor at The Ohio State Wexner Medical Center, Jennifer Roggenbuck, on January 20th at 2:00 PM EST for a live webinar to learn more about genetic testing in ALS.
2015 NEALS Research Ambassador, Dexter Ang, was awarded the ALS Assistive Technology prize by The ALS Association and Prize4Life during this year's ALS/MND International Alliance Meeting.